Investigation of Heart Rate Variability During the Menstrual Cycle

Completed

• Conditions: Ovulation

• Registration Number: NCT04008277
• Lead Sponsor: SPD Development Company Limited

Brief Summary

In this study, women will be required to wear a heart rate monitor continuously and collect daily early morning urine samples for the duration of one complete menstrual cycle. This will enable comparisons between data collected from the heart rate monitor and hormone analysis in urine samples to be made.

Detailed Description

This pilot study is a prospective observational study of women's heart rate and heart rate variability throughout one complete menstrual cycle. A minimum of 10 volunteers aged 18 years of age or over will be recruited via a variety of methods according to the criteria detailed in section 9. They will be required to wear a heart rate monitor continuously and collect daily early morning urine samples throughout one menstrual cycle.

Urine samples will be returned to SPD on a regular basis for measurement of urinary hormones related to pregnancy and fertility. Data collected via the monitor including heart rate and heart rate variability will be downloaded for comparison.

Study Timeline

• Study First Submitted: 2019-07-02
• Study First Submitted QC: 2019-07-02
• Study First Posted: 2019-07-05
• Study Start: 2019-07-19
• Primary Completion: 2019-10-02
• Study Completion: 2019-12-31
• Status Verified: 2020-02
• Last Update Submitted: 2020-02-19
• Last Update Posted: 2020-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 12

Inclusion Criteria

• Age 18 years and over
• Regular menstrual cycles

Exclusion Criteria

• Taking any hormonal medications
• Taking any medications that may affect heart rate
• Known heart condition or use of a pacemaker
• Skin condition where there is sensitivity to wearing a skin monitor
• Currently suffering with anxiety or panic attacks
• Pregnant or breastfeeding

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart Rate Variability	1 month	Heart rate variability at time points throughout the menstrual cycle
Heart Rate	1 month	Heart rate at time points throughout the menstrual cycle

Secondary Outcome Measures

Name	Time	Method
Fertile window	1 month	Fertile window onset determined by E3G surge
Day of ovulation	1 month	Day of ovulation determined by urinary LH surge +1 day
Fertile window closure	1 month	Fertile window closure determined by P3G rise

Trial Locations

Locations (1)

SPD Development Company Ltd.; 🇬🇧 Bedford, Bedfordshire, United Kingdom